An indirect confirmation that high levels of NRF2 adversely impact the prognosis of breast cancer patients comes from a quite recent study wherein the authors analyzed the expression data and clinical data from The Cancer Genome Atlas (TCGA) [59]. This evidence concerns the gene NFE2L2 and breast cancer.